| |
|
|
|
Harvard Bioscience  
|
|
3.01 -0.13 (-0.04%) |
10-21 15:21 |
|
Open: |
3.13 |
Pre close: |
3.14 |
Target:
|
3.75 
|
|
High: |
3.14 |
Low: |
3.01 |
Resistance:
|
3.21
3.50
|
|
Volume: |
19,803 |
Market Cap: |
120M |
Support:
|
2.74
2.28
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.18
|
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
3.15  |
Signal(12,26,9): |
0.00 |
|
MA(100): |
3.24 |
Stochastic Oscillator |
%K(14,3):
|
37.48 |
|
MA(250): |
2.93 |
%D(3): |
51.38 |
|
Average Volume(K) |
3-Month: |
11568
|
52-Week |
High:
|
4.41 |
|
10-Days: |
7178 |
Low: |
1.39 |
|
RSI |
RSI(14):
|
39.73 |
Change(%): |
9.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.214 |
Return on Equity (ttm) |
-10.4 |
Shares Out. (M) |
38.94 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
-0.7 |
Shares Float (M) |
34.63 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.80 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
-21.2 |
% Held by Institutions |
67.77 |
|
Forward EPS |
-0.080 |
Gross Profit (p.s.) |
1.658 |
Shares Short (K) |
1410 |
|
Book Value (p.s.) |
1.970 |
EBITDA (p.s.) |
0.156 |
P/E |
-14.07 |
|
Sales Per Share |
2.709 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.53 |
|
Profit Margin |
-7.74 |
Operating Cash Flow
(M) |
10.62 |
P/S |
1.11 |
|
Operating Margin |
-1.61 |
Levered Free Cash Flow
(M) |
13.47 |
P/CF |
11.04 |
|
|
|
|
|
|
